OTLK
Outlook Therapeutics Inc.
$1.26
+$0.02(+1.61%)
32
Overall
40
Value
25
Tech
--
Quality
Market Cap
$59.08M
Volume
445.02K
52W Range
$0.79 - $6.98
Target Price
$7.00
EPS Estimates Overview
| Current Quarter | $-0.23 | Next Quarter | $-0.21 |
| Current Year | $-1.79 | Next Year | $-0.84 |
| QoQ Growth | +8.7% | YoY Growth | +53.1% |
| 3Y EPS CAGR | -126.4% | Target Price | $7.00 |
| Consensus | Buy | Upside | +455.6% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | OTLK | $1.26 | +1.6% | 445.02K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Outlook Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW